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Abstract
Background:  The wide variety of real-time amplification platforms currently available has
determined that standardisation of DNA measurements is a fundamental aspect involved in the
comparability of results.
Statistical analysis of the data arising from three different real-time platforms was conducted in
order to assess inter-platform repeatability. On three consecutive days two PCR reaction mixes
were used on each of the three amplification platforms – the LightCycler®, ABI PRISM® 7700 and
Rotor Gene 3000™. Real-time PCR amplification using a fluorogenic 5' exonuclease assay was
performed in triplicate on negative controls and DNA plasmid dilutions of 108–102 copies to give
a total of 24 reactions per PCR experiment.
Results: The results of the statistical analyses indicated that the platform with the most precise
repeatability was the ABI PRISM® 7700 when coupled with the FastStart PCR reaction mix. It was
also found that there was no obvious relationship between plasmid copy number and repeatability.
An ANOVA approach identified the factors that significantly affected the results, in descending
order of magnitude, as: plasmid copy number, platform, PCR reaction mix and day (on which the
experiment was performed).
Conclusion: In order to deliver useful, informative genetic tests, standardisation of real-time PCR
detection platforms to provide repeatable, reliable results is warranted. In addition, a better
understanding of inter-assay and intra-assay repeatability is required.
Background
A diverse range of applications that impact on clinical
diagnosis and prognosis rely on the real-time detection
and quantification of Polymerase Chain Reaction prod-
ucts such as bacterial diagnostics [1,2], viral load [3-6],
cancerous cell burden [7,8] and parasite quantification
[9]. Each particular assay dictates the requirement for
instrument capacity, data reproducibility and run length
times. There is an expansive collection of different fluores-
cent chemistries and instruments available for real-time
amplification reactions [10-12]. These platforms repre-
sent a technological advance from the traditional thermal
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cycler and typically offer faster, smaller (reduced volume)
and more (high-throughput) reactions. Whilst the
number of instruments with different software and fluo-
rescent dyes is considerable, the obvious drawback is that
the resultant data may not be repeatable or even directly
comparable between instruments or even within instru-
ments on different runs. A statistically appropriate
number of samples and runs need to be conducted in
order to have confidence in the results or to assign math-
ematical significance to any of the factors affecting real-
time amplification. In addition, there is a shortage of reli-
able, universal DNA standards at present. Increasing
diversity through technological advances in DNA quanti-
tation instruments and software may further challenge the
standardisation of results. It should be ensured that
proper quality controls under-pin both existing and
emerging technologies.
The aim of this study was to evaluate the repeatability of
three different real-time PCR platforms including the
effect of PCR reaction mix. Previous work carried out has
shown that fluorogenic 5' exonuclease ("TaqMan®")
probe chemistry was more repeatable than Scorpion
probe or SYBR® Green I chemistries for genetically modi-
fied soya amplification on the LightCycler® (Roche Diag-
nostics, Lewes, UK) and the ABI PRISM® 7700 (Applied
Biosystems, Warrington, UK) [13]. Hence, for the amplifi-
cation of a 'model' plasmid dilution series we have
selected "TaqMan®" probes to assess inter-platform
repeatability of the LightCycler®, the ABI PRISM® 7700 and
the Rotor Gene 3000™ (Corbett Research, Cambridge,
UK). These three real-time PCR platforms have different
temperature control mechanisms, specifically a 96 well
heating block (ABI PRISM® 7700), an air fan and/or coil
with 32-position carousel (LightCycler®), and ambient air
with 72-position rotor (Rotor Gene 3000™) [10].
In addition the performance of two commercially availa-
ble master-mixes were compared. Statistical analysis was
performed on the data to assess the levels of inter-plat-
form repeatability and dynamic range of the instruments
with different master-mixes.
Results
Repeatability Estimates
Precision estimates were determined based on each plat-
form with PCR reaction mix combination at every plas-
mid copy number across the three days using ISO
guidelines [14]. Precision estimates were calculated as
repeatability standard deviations of the Ct (threshold
cycle number) values from the amplification of each plas-
mid dilution. In addition, the mean value and standard
deviations of these repeatability standard deviations were
also presented in Table 1 to provide a measure of the var-
iance of these estimates. Percentage coefficients of vari-
ance (%CV) were not used to represent precision
estimates as a low mean Ct value in this experiment is
indicative of good precision and therefore percentage CV
would generate misleading results.
Although the assay was not designed to assess biological
sensitivity of the system, and the dilution levels did not
Table 1: Comparison of repeatability estimates of the PCR measurements using different reaction mixes and platforms over three 
days (using standard deviations of the Ct value).
Repeatability Estimates (standard deviations of the Ct value) based on Individual Plasmid Copy Number
Plasmid Copy 
Number
Platform and PCR Reaction Mix
ABI 7700 LightCycler RotorGene
Excite FastStart Excite FastStart Excite FastStart
102 0.543 0.182 0.568 0.233 0.888 0.186
103 0.452 0.204 1.177 0.190 0.184 0.445
104 0.223 0.305 1.123 0.100 0.256 0.592
105 0.243 0.168 0.947 0.224 0.209 0.221
106 0.362 0.183 1.378 0.281 0.772 0.333
107 0.473 0.189 0.919 0.156 0.319 0.247
108 0.236 0.184 0.454 0.352 0.322 0.166
Degrees of Freedom 6–8 6 6–8 5–6 6–8 6
Mean 0.362 0.202 0.938 0.219 0.421 0.313
Standard Deviation 0.130 0.047 0.331 0.082 0.286 0.156
(Note that one replicate is missing for the LC platform coupled with the Fast Start reaction mix – the capillary broke).BMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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approach the limit of detection for the system, the 108
plasmid copy number data set had the best overall preci-
sion associated with it. The most probable reason for this
is the availability of the target analyte in the sample.
The ABI PRISM® 7700 had the lowest mean repeatability
estimate of all the platforms in this study when combined
with the FastStart reaction mix, as shown in Table 1. How-
ever, the means of the repeatability estimates for the two
PCR reaction mixes when combined with this platform
were different (0.202 for the FastStart mix and 0.362 for
the Excite™ mix). With the exception of the 104 plasmid
copy number, every repeatability estimate value for the
reactions performed on the ABI PRISM® 7700 using Fast-
Start was lower than the corresponding Excite™ reaction
mix. Indeed, consistently across the three platforms, the
FastStart mix had the lowest average repeatability esti-
mates in this trial. The value of the mean and standard
deviations of the repeatability estimates were comparable
when the FastStart PCR reaction mix was employed on the
ABI PRISM® 7700 and on the LightCycler® (0.202 and
0.219 respectively and 0.047 and 0.082 respectively).
The lowest repeatability estimate calculated in this study
was found to be 0.100. This value was generated on the
LightCycler® using the FastStart reaction mix and a plas-
mid copy number of 104. Conversely, the highest repeata-
bility estimate (1.378) was also produced on the
LightCycler®  but the Excite™ PCR reaction mix was
employed with a plasmid copy number of 106.
Unexpectedly, the highest repeatability estimates for each
data set are not necessarily associated with the low plas-
mid copy numbers [15]. The lowest repeatability esti-
mates and the highest repeatability estimates for each
platform and PCR reaction mix data set show no discern-
ible trend with respect to plasmid copy number.
The least repeatable system in this trial based upon the
data in Table 1 was the combination of the LightCycler®
with the Excite™ PCR reaction mix. Comparison with the
results of other published studies was not possible, as the
statistical methods used were not clearly reported in the
literature.
Analysis of Variance
An ANOVA approach using the threshold cycle number
was used to identify sources of variability within the data.
Table 2 shows the significance levels of the four main fac-
tors of day, plasmid copy number, reaction mix, and plat-
form, as well as the significance levels of the interaction
terms. The factors and interaction terms were compared to
the Error MS (mean square) in order to assess their
significance.
Table 2: Variation attributable to day, plasmid copy number, PCR reaction mix and platform following an ANOVA test using threshold 
cycle number (Ct) as the variable factor.
Univariate Tests of Significance for Ct value. Sigma-
restricted parameterisation. Effective hypothesis 
decomposition.
Effect SS DF MS F P
Day 96.0 2 48.0 221.4 <0.00001
Plasmid Copies 12919.2 6 2153.2 9932.0 <0.00001
PCR Reaction Mix 75.0 1 75.0 346.2 <0.00001
Platform 700.5 2 350.2 1615.5 <0.00001
Day with Plasmid Copies 53.2 12 4.4 20.5 <0.00001
Day with PCR Reaction Mix 1.9 2 0.9 4.3 0.01442
Plasmid Copies with PCR Reaction Mix 8.5 6 1.4 6.5 <0.00001
Day with Platform 130.8 4 32.7 150.8 <0.00001
Plasmid Copies with Platform 51.0 12 4.2 19.6 <0.00001
PCR Reaction Mix with Platform 1.7 2 0.9 4.0 0.01901
Day with Plasmid Copies with PCR Reaction Mix 14.6 12 1.2 5.6 <0.00001
Day with Plasmid copies with Platform 18.3 24 0.8 3.5 <0.00001
Day with PCR Reaction Mix with Platform 49.6 4 12.4 57.1 <0.00001
Plasmid copies with PCR Reaction Mix with Platform 4.5 12 0.4 1.7 0.06337
Day with Plasmid Copies with PCR Reaction Mix with Platform 11.8 24 0.5 2.3 0.00091
Error 54.4 251 0.2
(Where SS = sum of squares; DF = degrees of freedom; MS = Mean Square; F = ratio of variances; p = probability of obtaining a specific result, given 
by the null hypothesis).BMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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All four individual factors were highly significant. From
the calculated F-variance ratio the factor of day had the
least significant effect of the four factors, followed by PCR
reaction mix (approximately 1.5 times the effect of day),
then platform (approximately 7 times the effect of day),
and then, as expected, plasmid copy number (approxi-
mately 45 times the effect of day). Even though the effect
of day had a significant effect upon the results, this effect
was very small when compared to the effect of platform
and plasmid copy number.
The interaction of the four main factors was also investi-
gated, this demonstrated that the majority of interaction
terms were significant. However, in general the magnitude
of the effect of these interaction terms was very small com-
pared to the effect of the four main factors.
Day Effect
Day had a statistically significant effect upon the Ct value
of the raw data (P<0.00001). The average Ct value in the
full data set decreased from 19.76 to 18.54 across the 3
days (data not shown).
Plasmid Dilution Effect
As Figure 1 illustrates, the number of plasmid copies was
inversely proportional to the average Ct value [6,12]
within the instrument dynamic working range and above
the LOD (limit of detection). Our results concur with
Sanchez et al [5] who reported that cytomegalovirus quan-
tification was linear between 101 and 106 copies, and with
Moberg et al who used 102 to 107 DNA copies in their real-
time assay [16]. At extremely low or high plasmid copy
numbers the linear relationship with Ct value may be
affected. At high copy number it may be difficult to set an
accurate baseline because threshold values will be reached
after only a few amplification cycles. In addition, reac-
tions with very low numbers of target molecules may be
disproportionately affected by pipetting errors and by sto-
ichiometric effects. This highlights the need to work
within the linear dynamic range of the instrument and the
potential inaccuracy introduced by extrapolation of cali-
bration curves.
Fresh plasmid dilutions were utilised to counteract the
previously observed progressive loss of intact plasmid
DNA, particularly at low plasmid copy number dilutions.
This is probably due to physical adhesion of the DNA to
the tube walls, although precautions, such as the use of sil-
iconised tubes, were undertaken.
Fresh plasmid dilutions were made each day. Figure 2
illustrates how the average Ct value alters across the three
days (which have three different dilution sets) for each
plasmid copy number.
PCR Reaction Mix Effect
The results from reactions containing FastStart mix had
significantly lower average Ct values than their Excite™ 2x
mix reaction counterparts (data not presented) – the dif-
ference is approximately 1 cycle per plasmid dilution. The
smallest interaction term is that of PCR reaction mix with
platform (P = 0.019), indicating good consistency of
results when using the reaction mixes across different
platforms.
Platform Effect
The platforms have different heating mechanisms and
therefore it was expected that their performance character-
istics such as repeatability might differ significantly. The
largest significant interaction term (F = 150.8) was that of
platform with day, indicating that each platform may not
be behaving consistently between the three days. Closer
inspection of the data shows that the majority of the vari-
ation associated with the platform by day interaction is
attributed to the Rotor Gene day 2, as illustrated in Figure
3, which appears inconsistent compared to the other two
platforms. This interaction effect of platform with day was
not significantly different from the factor of day or PCR
reaction mix. The interaction of PCR reaction mix and
platform (shown in Table 2) was found to be statistically
significant at the 5% level.
The full raw data set is available [see Additional file 1].
Discussion
Use of a 'model' system that contained little or no con-
taminants, coupled with a balanced experimental design
enabled accurate assessment of repeatability. Other
factors such as extraction methods and complex matrices
can potentially increase analytical variability. As demon-
strated by the present study, a range of factors can affect
performance of each of the instruments. In addition,
results are influenced by the threshold value settings
applied to the machine by the analyst. To underpin mean-
ingful quantitative PCR measurement, internationally
accepted guidelines should be established to standardise
the analysis and interpretation of real-time PCR results.
PCR reference standards could also be used as indicators
of instrument reliability and amplification efficiency
[17,18], while internal reaction controls could addition-
ally monitor effects of PCR inhibitors and normalise for
any instrument non-uniformity. A recent publication has
looked at the plateau phase and the effect of enzyme inhi-
bition during this stage of amplification [19]. With regard
to analysis and software compatibility, a study conducted
by Kuhne and Oschmann [20] has demonstrated the fea-
sibility of importing standard curves from different Light-
Cycler runs. Historically, standard curves have been the
method of choice for determining absolute DNA concen-
tration. However, the quantity of the standards usedBMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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should be accurately calculated by gravimetry or other pri-
mary methods, as absorbance at a wavelength of 260 nm
is not sufficient alone. Our present study has shown the
potential inaccuracies introduced by importing standard
curves, considering the significance of the factor 'day' on
the data presented. Even under the controlled conditions
used in the present study, significant variability was
observed, suggesting that transferring standard curves
between runs could be unreliable unless adequate con-
trols are used. Recent research using more sophisticated
software approaches has demonstrated the ability to use
grand mean calibration curves between runs following
compensation for differences in amplification efficiency
[21]. Amplification efficiency changes throughout the
course of a PCR reaction and is dependent on enzyme
kinetics [22,23]. The potential pitfall of assuming that the
sample analyte has the exact same kinetics and amplifica-
tion efficiency of the standards has been highlighted
recently [15]. A Galton-Watson branching process has
been proposed which involves considering the number of
molecules present during PCR cycles and uses Michaelis-
Menten enzyme kinetics together with a population
growth approach [23]. One other source of uncertainty
associated with using amplification curves is the issue of
handling outlier data points. In a recent publication Bar et
al discussed this subject and presented a new statistical
method [24]. This may have applications for clinical sam-
ples that have been extracted from complex matrices or
Average threshold cycle number (Ct) plotted against plasmid copy number Figure 1
Average threshold cycle number (Ct) plotted against plasmid copy number. The data have been pooled from each 
platform, PCR reaction mix and day to give an average Ct value. Linear regression performed on the ploted data values from 
this graph determined that the gradient was -2.92 and that the amplification efficiency [21] was greater than two. However the 
amplification efficiency cannot be greater than two since PCR is an exponential reaction where the amount of product doubles 
at each cycle.BMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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any analysis with high levels of variability between results.
It is not surprising that difficulties in data comparison
arise due to the many different mathematical and software
approaches applied to real-time quantitative PCR, despite
sharing the same mathematical fundamentals [25-28].
The data generated in this study is not intended to indi-
cate any preference for a particular piece of equipment or
PCR reaction mix. The instrument specification, reliabil-
ity, operator training, servicing and comparability all con-
tribute to overall assay precision. In choosing a real-time
platform, we would recommend that users consider the
statistical outcomes of our results and perform their own
critical assessments to ensure that an instrument is fit for
their purpose. Generally any such judgement would
involve factors such as the volume of samples for process-
ing, the speed at which results need to be obtained and the
reproducibility or repeatability of the results.
In addition to choice of appropriate real-time platform,
accurate quantitative measurement is dependent upon
rational experimental design, optimisation and careful
data interpretation.
Conclusion
We have demonstrated that in this trial the most repeata-
ble system was the ABI PRISM® 7700 with the FastStart
PCR reaction mix. However the mean repeatability esti-
mate of the LightCycler® combined with the FastStart mix
was comparable. In addition, we have shown that the
plasmid copy numbers used in this trial did not display a
distinct relationship with instrument repeatability.
Average threshold cycle number (Ct) plotted against day for each plasmid dilution illustrating the interaction of day and plasmid  copies Figure 2
Average threshold cycle number (Ct) plotted against day for each plasmid dilution illustrating the interaction 
of day and plasmid copies. The data have been pooled from each platform, PCR reaction mix and plasmid dilution.BMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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An ANOVA established that plasmid copy number, plat-
form, PCR reaction mix and day significantly affected the
results in a descending order of magnitude.
Inherent differences in the data handling between instru-
ments still presents a challenge to the normalisation of
real-time PCR assays between laboratories and users of
different instruments. We have confirmed that standard-
ised real-time PCR detection instruments and data
analysis approaches are imperative in order to guarantee
the integrity and the repeatability of DNA measurement
experiments.
Methods
Plasmid Composition and Dilution
The target DNA was a pPCR-Script Amp SK(+) plasmid
(Stratagene, Amsterdam, The Netherlands) with an insert
at the Srf I site in the multiple cloning site (supplied by
N.I.S.T, Gaithersburg, MD, USA). A portion of the insert
sequence follows with the primer binding sites indicated
in bold face type and the probe binding site underlined:
5'-
CAGACCGCTCGACGATAGGTCAGCACTGTCTCGTTGA
CAGGCGTGGTCAATCAGCCTGAAATCCTCGATCA-
GAGTGTGCCGATCTCTGGTCCACGTCCT-3'. From a
stock solution of plasmid (3 × 1013 copies) in molecular
biology grade water (Sigma, Poole, UK), 1 in 10 serial
dilutions were carried out to a copy number of 3 × 105 per
mL using the same batch of water. Fresh dilutions were
made every day from the same stock and using the same
conditions and were kept at 4°C before and between use.
At low copy numbers particularly, a reduction in target
copies available for amplification was observed on pro-
longed storage, possibly due to DNA absorption to the
Average threshold cycle number (Ct) plotted against day for each platform illustrating the interaction of day and platform Figure 3
Average threshold cycle number (Ct) plotted against day for each platform illustrating the interaction of day 
and platform. The data have been pooled from each PCR reaction mix and plasmid dilution.BMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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walls of the tube (data not shown). Fresh dilutions were
prepared each day in order to minimise this source of
variation.
Real-time PCR Conditions
A 100-bp region of the insert sequence was amplified
using HPLC purified oligonucleotide primers (Sigma-
Genosys, Cambridge, UK) and a fluorogenic 5' exonucle-
ase probe (Sigma-Genosys, Cambridge, UK) diluted in
molecular biology grade water (Sigma, Poole, UK). The
primers and probe used were P1A (forward primer): 5'-
ACAGACCGCTCGACGATAGG-3', P1B (reverse primer):
5'-AGGACGTGGACCAGAGATCG-3' and TAQ1 (probe):
5'-{FAM}CAGCACTGTCTCGTTGACAG-
GCGTG{TAMRA}-3' (FAM – 6-carboxyfluoresceine;
TAMRA – 5'-carboxytetramethylrhodamine).
Primer Express®  software (Applied Biosystems; War-
rington, UK) was used to design the primers and probe.
The thermal cycling conditions used were dependent on
the PCR reaction mix employed and were optimised pro-
tocols based on the manufacturer's guidelines. Amplifica-
tion conditions for those reactions that contained
'FastStart Master mix' (Roche Diagnostics, Lewes, UK)
were a 10 minute hold at 95°C followed by 55 cycles of
95°C for 15 seconds and 60°C for 30 seconds. For reac-
tions with the Excite™ 2x kit (Biogene, Kimbolton, UK)
the amplification conditions were a 2 minute hold at
50°C followed by a 10 minute hold at 95°C and then 55
cycles of 95°C for 15 seconds and 60°C for one minute.
Instrumentation & PCR Reaction Mixes
Three platforms compatible with "TaqMan®" probes were
assessed – LightCycler® (Roche Diagnostics, Lewes, UK),
ABI PRISM® 7700 (Applied Biosystems, Warrington, UK)
and Rotor Gene 3000™ (Corbett Research, Cambridge,
UK). All of these instruments were found to be compati-
ble with FastStart (Roche Diagnostics, Lewes, UK) and
Excite™ 2x (Biogene Kimbolton, UK) mixes following
optimisation. The amplification performances of both
PCR reaction mixes were investigated on each of the three
machines using the plasmid dilution series as target. The
probe was added at a final concentration of 200 nM per
reaction for all experiments. The Primers P1A and P1B
were used at a final concentration of 1500 nM each in the
Excite™ mix reactions whereas the FastStart mix reactions
contained the primers at a final concentration of 500 nM
each. A supplement of magnesium chloride (final concen-
tration of 3 mM) was added to those reactions containing
Excite™ mix that were run on the LightCycler®. In addition,
magnesium chloride at a final concentration of 3 mM was
required for all those reactions containing the FastStart
mix except for the equivalent amplification reactions run
on the LightCycler®, where a final concentration of 2 mM
of magnesium chloride was optimal.
A solution of BSA (BSA 100x; New England Biolabs,
Hitchin, UK) at a final concentration of 0.1 mg/mL was
added to the Excite mix for reactions run on the
LightCycler®. To every reaction except the negative con-
trols, 1 µL of plasmid DNA was added. Additional molec-
ular biology grade water was added to a final volume of 20
µL and 25 µL for the FastStart and Excite™ mixes
respectively.
Reactions were set up in 20 µL glass capillaries, 0.1 mL
plastic tubes and 96 well optical plates for use on the
LightCycler®, Rotor Gene 3000™ and ABI PRISM® 7700
respectively.
Experimental Design
Six experiments (two per platform) were run, and
repeated for three consecutive days. Three replicates of
each plasmid DNA dilution plus three negative controls
(24 reactions in total) were amplified per experiment.
One specific analyst prepared the complete master-mixes
containing primers, probes, water and other supplements
as already outlined, in a pre-PCR 'clean' room using the
same pipettes each day. A second specific analyst added
the plasmid DNA in a dedicated template addition area
and used the same instruments for all template additions.
Those amplification reactions containing the Excite™ 2x
mix were run at the same time each morning on the Rotor
Gene 3000™, ABI PRISM® 7700 and LightCycler® and the
reactions containing FastStart mix were run at the same
time each afternoon on the Rotor Gene 3000™, ABI
PRISM® 7700 and LightCycler®. For each run the same
instrument, rotor and carousel (where applicable) were
employed to minimise intra-run variability.
Baseline Settings & Data
The Ct (threshold cycle number) was used as the measur-
and in order to assess the level of product in proportion to
the level of starting target. As recommended by the manu-
facturers' guidelines, the Ct values were calculated from
the mid-point of the exponential phase of amplification.
However, each real-time platform required some manual
intervention to set analysis parameters. In addition spe-
cific analysis software was associated with each instru-
ment and inherent differences in data manipulation may
introduce further inter-platform variability. As amplifica-
tion efficiency has been shown to change over the course
of the reaction [29], we have based our analysis on the
mid-point of the exponential phase to measure threshold
cycles irrespective of platform, run or PCR reaction mix.
Statistical Analysis
The results were interpreted and analysed according to the
instrument manufacturer protocols. For each platform,
graphs of cycle number versus arbitrary fluorescence units
were generated and from this raw data, Ct values wereBMC Biotechnology 2005, 5:15 http://www.biomedcentral.com/1472-6750/5/15
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automatically calculated by the software provided with
each instrument [see Additional file 1]. The statistical
package Statistica 6.0 (Statsoft; Tulsa, OK, USA) was used
to analyse the data for all the instrument runs by ANOVA
(Analysis of Variance) and then repeatability estimates
were carried out.
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TAMRA: 5-carboxytetramethylrhodamine
BSA: bovine serum albumin
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%CV: Percentage coefficient of variance
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